He is Professor of Bioengineering and Materials Science at UC Berkeley and Faculty Scientist at Lawrence Berkeley National Laboratory. He is a Fellow of the Royal Society of Chemistry, the American Institute for Medical and Biological Engineering, the Materials Research Society and the American Association for the Advancement of Science. In addition to his research, he mentors and teaches students in the fields of biomaterials design, materials science, polymer science, and nanomedicine.

Faculty host: Felipe Quiroz

 

Special emphasis is given to Tissue Engineering and Regenerative Medicine and particular applications and more details are described on the lab web page.

Faculty host: Alexander Vlahos

 

BIO
Jeffrey Hubbell is a pioneer in the field of immuno-modulatory materials whose research spans biology, chemistry, and engineering to generate novel solutions to common health problems. His work focuses on using biomaterials and engineered proteins to enhance the body’s own immune system to fight inflammatory and autoimmune disorders, allergies, and disease states like cancers. With more than 400 papers and 100 issued US patents, Hubbell uses biomaterials and protein engineering approaches to investigate topics in regenerative medicine and immunotherapeutics. In regenerative medicine, he develops both materials and protein therapeutics to address issues such as chronic wound healing in diabetes and bone repair after trauma. In immunotherapeutics, he pursues nanomaterials in vaccination for infectious disease and cancer as well as targeted therapy with RNA, protein-material conjugates for inverse vaccines to induce antigen-specific tolerance in autoimmunity and allergy, and in protein therapy to tip immune balances toward aggression in immuno-oncology and toward tolerance in inflammatory disease. His interests are both basic and translational, having founded or co-founded six biomedical companies based on his technology.

Before moving to New York University, Hubbell was at the University of Chicago in the Pritzker School of Molecular Engineering, where he helped build its strength in immunoengineering. Prior to that, he was on the faculty of the Swiss Federal Institute of Technology Lausanne (EPFL, where he served as founding Director of the Institute of Bioengineering and Dean of the School of Life Sciences), the Swiss Federal Institute of Technology Zurich (ETHZ) and University of Zurich, the California Institute of Technology, and the University of Texas in Austin. He was elected to the US National Academy of Engineering in 2010, the National Academy of Medicine in 2019, the American Academy of Arts and Sciences in 2021, and the National Academy of Sciences in 2023.

Zoom link for virtual participation

Digital technologies are reshaping our work and our lives at unprecedented speed. This presentation examines three forces driving this Fourth Industrial Revolution: exponentiality, convergence, and ubiquity, and their implications for higher education and adult learning. Dr. Schatz explores critical questions: How do we leverage AI-enabled personalization to support careers when 40% of worker skills become obsolete every five years? How do we design learning ecosystems that scale adaptive support across institutional boundaries? How do we use data to inform lifelong learning while respecting individuals’ data sovereignty? Drawing on cognitive science and learning engineering research, this presentation offers actionable strategies for implementing AI-augmented adult learning systems that move from pilot projects to institutional practice.

Biosketch

Sae (pronounced like “say”) works at the intersection of cognition, technology, and data. She specializes in bridging the gap between scientific principles and human-centered practice, and her unique approach to “strategic storytelling” (translating complex topics into memorable messages) has garnered professional awards and seen her work translated into multiple languages. 

In 2023, Sae launched the Knowledge Forge LLC, a boutique consultancy offering keynotes, professional development workshops, and strategic services. Her clients include government agencies, academic institutions, and businesses. Recently, for example, she delivered keynotes at the UK Special Forces Club (Knightsbridge), Prometric board meeting, and Innovations in Testing annual conference. She’s published works in TD Magazine, Defense Dossier, and the Journal of Military Learning, and she helped to produce the Learning Engineering Toolkit (2022), authored Engines of Engagement: A Curious Book About Generative AI (2023), and contributed to the U.S. National Academies’ report on Adult Learning in the Military Context (2024). 

From 2015 to 2022, Sae served as the director of the Advanced Distributed Learning (ADL) Initiative, a U.S. Department of Defense program for research, development, and policy stewardship. She also co-chaired the NATO Training Group (NTG) Individual Training and Educational Developments task group. Under her leadership, the U.S. ADL Initiative sparked the international community’s pursuit of the lifelong “digital learning ecosystem,” in part with her popular book Modernizing Learning: Building the Future Learning Ecosystem. Her efforts were also formally recognized as “a pathfinder for enterprise data services” by then–DoD Chief Data Officer David L. Spirk. 

Before joining the civil service, Sae worked as an applied human-systems scientist in both business and academia. From 2011 to 2014, she was the chief scientist at MESH Solutions (a defense contractor), where she led the U.S. Marine Corps’ Making Good Instructors Great project and the U.S. Joint Staff’s award-winning Blended Learning–Training effort. Prior to that, she held an assistant professorship with the University of Central Florida’s Institute for Simulation and Training. Sae is a prolific writer and professional presenter as well as a graphic designer who often uses those skills to enhance books, presentations, and infographics. 

She holds a doctorate in Modeling and Simulation (M&S), with an emphasis on human systems.

Join us for lunch to learn how to better leverage the incredible resources available via your IBB Core Facilities! Lunch provided for registered attendees. 

Register to attend 

 

Join faculty from across the Georgia CTSA for an energetic and dynamic virtual networking session!

BIO
Marcela Maus grew up in New York, NY and attended Massachusetts Institute of Technology for her undergraduate degree in Biology and Literature. She then earned her MD, PhD from the University of Pennsylvania School of Medicine where she studied the biology of human T cell activation under the direction of her PhD mentor, Dr. Carl June. After completing her doctorate degrees, Marcela did a one-year postdoctoral fellowship with Dr. Kathy High at the Children’s Hospital of Philadelphia studying patient immune responses to liver-directed AAV-mediate gene transfer as a treatment for hemophilia. She then completed her clinical training in internal medicine, hematology, and oncology as a resident at the University of Pennsylvania Health System and a fellow at Memorial Sloan Kettering Cancer Center. While at Memorial Sloan Kettering, she worked in Michel Sadelain’s lab to engineer new genetically modified T cells to target the cancer-testis antigen NY-ESO-1 and received specialized training in Phase I developmental therapeutics. She was also awarded a K08 grant by the NIH to facilitate her transition to a faculty position.

Following her extensive training (11 years), Marcela returned to the University of Pennsylvania in 2012, where she was recruited by her former PhD mentor, to expand their research efforts in the development of CAR T cells for lymphoma, myeloma, and other cancers. While there, Marcela continued her efforts on preclinical development of CAR T cells and correlative studies of CAR T cell-related toxicities and resistance to therapies. They discovered and reported on the first cases of anaphylaxis to CAR T cells and off target cross-reactivity. She also led an entire arc of translational research, from preclinical testing to a first-in-human clinical trial of EGFRvIII CAR T cells for treatment of recurrent glioblastoma. Correlative data collected from this trial led to an understanding of CAR T resistant mechanisms that have led further refinement of these CAR T cells, which is one current area of focus in her current laboratory and has led to the development of another Phase I clinical trial for GBM patients.

Now, Dr. Maus is a Professor of Hematology and Oncology at Massachusetts General Hospital and Harvard Medical School, where she runs a laboratory focused on developing and improving CAR T cell therapy for cancer patients while also periodically attending for the bone marrow transplant service. Marcela is the Paula O-Keeffe Endowed Chair of the Massachusetts General Hospital Cancer Center and the Director of the Cellular Immunotherapy Program. She has won numerous awards for her transformative research and is achieving her goal of using science to determine the best way to treat patients by harnessing the power of the immune system to solve intractable problems like cancer. She also enjoys training clinicians and scientists and watching her mentees succeed and become independent scientists and collaborators.

Shawn Burke, Presenter

Establishing and maintaining a productive research team is a difficult challenge across all stages of an academic’s career. The science of good teamwork applies across an academic career: from incorporating graduate students and post-docs to your first research team to crossing-boundaries in the creation and maintenance of an interdisciplinary expert team. In conjunction with Georgia Clinical and Translational Science Alliance, we are offering a skill series to develop the skills necessary to build and maintain your research team by leveraging existing teams research. This workshop will focus on leadership within your team. Graduate students, post-docs, and all levels of academic faculty are all welcome to attend this workshop.

Team consult opportunity:

Our Team Science Skills presenters have graciously opened their schedules to provide a limited amount of attendees with direct feedback and guidance on their personal team issues. During a one-hour consulting session, attendees will be able to directly ask our experts questions and get personalized advice on how to effectively move their team forward.  Requesters must attend the full session and complete the post-evaluation survey to be eligible.